Aurinia Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA05156V1022
USD
14.53
-0.33 (-2.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1110640,
    "name": "Aurinia Pharmaceuticals, Inc.",
    "stock_name": "Aurinia Pharmaceuticals, Inc.",
    "full_name": "Aurinia Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/aurinia-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "14.53",
    "chg": -0.33,
    "chgp": "-2.22%",
    "dir": -1,
    "prev_price": "14.86",
    "mcapval": "1,948.60",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "CA05156V1022",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "1.93 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurinia-pharmaceuticals-inc-1110640-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aurinia Pharmaceuticals Hits New 52-Week High of $16.20",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurinia-pharmaceuticals-hits-new-52-week-high-of-1620-3674046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AuriniaPharmace_priceRelatedfactors_3674046.png",
        "date": "2025-11-05 16:48:31",
        "description": "Aurinia Pharmaceuticals, Inc. achieved a new 52-week high of USD 16.20, reflecting its strong performance in the pharmaceuticals sector. The company has seen significant stock growth, positive net sales, and profits, alongside a solid financial profile and high institutional ownership, reinforcing its market position."
      },
      {
        "title": "Aurinia Pharmaceuticals Hits Day High with 8.66% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurinia-pharmaceuticals-hits-day-high-with-866-surge-in-stock-price-3667397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AuriniaPharmace_priceRelatedfactors_3667397.png",
        "date": "2025-11-03 17:44:49",
        "description": "Aurinia Pharmaceuticals has shown strong stock performance, gaining 8.66% on October 31, 2025, and outperforming the S&P 500 over the past year. The company reported a 12.08% increase in net sales and positive results for five consecutive quarters, reflecting robust operational strength and effective capital utilization."
      }
    ],
    "total": 22,
    "sid": "1110640",
    "stock_news_url": "https://www.marketsmojo.com/news/aurinia-pharmaceuticals-inc-1110640"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available